Ryali Sriram 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Sep 6, 2019
Insider Transaction Report
Form 4
Ryali Sriram
Chief Financial Officer
Transactions
- Award
Common Stock
2019-09-05$9.37/sh+149$1,396→ 1,399 total
Footnotes (1)
- [F1]These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).